Search research articles
Contact Us
Filters
Showing results (611-620 of 686) with videos related to
Page
of 69
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 16, 2015
Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy
Samantha E Jacobs, Daryl M Lamson, Rosemary Soave, et al.
British Journal of Haematology
|
January 29, 2014
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
Peter J Hosein, Jocelyn C Maragulia, Matthew P Salzberg, et al.
The Lancet. Haematology
|
December 5, 2016
Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study
Richard R Furman, Herbert A Eradat, Christine G DiRienzo, et al.
The American Journal of Pathology
|
June 7, 2011
Inhibiting TGF-β activity improves respiratory function in mdx mice
Carol A Nelson, R Bridge Hunter, Lindsay A Quigley, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 23, 2016
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma
Tiffany Tang, Zhengming Chen, Pannee Praditsuktavorn, et al.
Cancer Medicine
|
February 17, 2023
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
Pallawi Torka, Levi D Pederson, Michael V Knopp, et al.
Leukemia & Lymphoma
|
May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816
Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Blood Advances
|
March 3, 2025
Nivolumab plus relatlimab in patients with relapsed or progressed B-cell malignancies in RELATIVITY-022
Ajay K Gopal, Philippe Armand, Sattva S Neelapu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2018
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus <sup>131</sup>I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016
Mazyar Shadman, Hongli Li, Lisa Rimsza, et al.
British Journal of Haematology
|
October 28, 2008
Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma
Tomer Mark, David Jayabalan, Morton Coleman, et al.
Page
of 69
Search research articles
Search
Showing results (611-620 of 686) with videos related to
Sort By:
Page
of 69
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 16, 2015
Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy
Samantha E Jacobs, Daryl M Lamson, Rosemary Soave, et al.
British Journal of Haematology
|
January 29, 2014
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
Peter J Hosein, Jocelyn C Maragulia, Matthew P Salzberg, et al.
The Lancet. Haematology
|
December 5, 2016
Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study
Richard R Furman, Herbert A Eradat, Christine G DiRienzo, et al.
The American Journal of Pathology
|
June 7, 2011
Inhibiting TGF-β activity improves respiratory function in mdx mice
Carol A Nelson, R Bridge Hunter, Lindsay A Quigley, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 23, 2016
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma
Tiffany Tang, Zhengming Chen, Pannee Praditsuktavorn, et al.
Cancer Medicine
|
February 17, 2023
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
Pallawi Torka, Levi D Pederson, Michael V Knopp, et al.
Leukemia & Lymphoma
|
May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816
Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Blood Advances
|
March 3, 2025
Nivolumab plus relatlimab in patients with relapsed or progressed B-cell malignancies in RELATIVITY-022
Ajay K Gopal, Philippe Armand, Sattva S Neelapu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2018
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus <sup>131</sup>I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016
Mazyar Shadman, Hongli Li, Lisa Rimsza, et al.
British Journal of Haematology
|
October 28, 2008
Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma
Tomer Mark, David Jayabalan, Morton Coleman, et al.
Page
of 69